COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE IN COMPARISON TO TRIVALENT INFLUENZA VACCINE IN BRAZIL USING A DYNAMIC MODEL

Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong

BMC Infectious Diseases ◽

10.1186/s12879-014-0618-9 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 27

Author(s):

Joyce HS You ◽

Wai-kit Ming ◽

Paul KS Chan

Keyword(s):

Hong Kong ◽

Cost Effectiveness ◽

Influenza Vaccine ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

PIN60 Cost-Effectiveness of Quadrivalent Influenza Vaccine High Dose Versus Adjuvanted Standard Dose Trivalent Influenza Vaccine in England

Value in Health ◽

10.1016/j.jval.2020.08.901 ◽

2020 ◽

Vol 23 ◽

pp. S555

Author(s):

I. Gibbons ◽

C. Davidson ◽

J. Clark-Wright ◽

C. Miller ◽

S. Carroll ◽

...

Keyword(s):

Cost Effectiveness ◽

Influenza Vaccine ◽

Standard Dose ◽

High Dose ◽

PIN32 Cost-Effectiveness of the CELL-Based Quadrivalent Versus the Standard Egg-Based Quadrivalent Influenza Vaccine in Germany.

Value in Health ◽

10.1016/j.jval.2020.08.873 ◽

2020 ◽

Vol 23 ◽

pp. S549

Author(s):

R. Cai ◽

M. Eichner ◽

M. Schwehm ◽

S. Rajaram ◽

M.Q. Joaquin F. ◽

...

Keyword(s):

Cost Effectiveness ◽

Influenza Vaccine ◽

Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany

Journal of Medical Economics ◽

10.1080/13696998.2021.1908000 ◽

2021 ◽

pp. 1-1

Author(s):

Rui Cai ◽

Laetitia Gerlier ◽

Martin Eichner ◽

Markus Schwehm ◽

Sankarasubramanian Rajaram ◽

...

Keyword(s):

Cost Effectiveness ◽

Influenza Vaccine ◽

Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina

Vaccine ◽

10.1016/j.vaccine.2020.02.081 ◽

2020 ◽

Vol 38 (20) ◽

pp. 3682-3689 ◽

Cited By ~ 1

Author(s):

Van Hung Nguyen ◽

Carla Vizzotti ◽

Analia Uruena ◽

Norberto Giglio ◽

Cecilia Magneres ◽

...

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Influenza Vaccine ◽

Trivalent Influenza Vaccine

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial

Vaccine ◽

10.1016/j.vaccine.2014.01.022 ◽

2014 ◽

Vol 32 (13) ◽

pp. 1480-1487 ◽

Cited By ~ 51

Author(s):

Juan Carlos Tinoco ◽

Noris Pavia-Ruz ◽

Aurelio Cruz-Valdez ◽

Carlos Aranza Doniz ◽

Vijayalakshmi Chandrasekaran ◽

...

Keyword(s):

Influenza Vaccine ◽

Randomized Trial ◽

Vaccine Candidate ◽

Healthy Adults ◽

Phase Iii ◽

PIN70 COST-EFFECTIVENESS OF SEASONAL VACCINATION WITH QUADRIVALENT INFLUENZA VACCINE IN PORTUGAL

Value in Health ◽

10.1016/j.jval.2019.09.1311 ◽

2019 ◽

Vol 22 ◽

pp. S651

Author(s):

J. Almeida ◽

C. Ferreira ◽

S. Monteiro

Keyword(s):

Cost Effectiveness ◽

Influenza Vaccine ◽

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States

Value in Health ◽

10.1016/j.jval.2014.08.2528 ◽

2014 ◽

Vol 17 (7) ◽

pp. A679

Author(s):

P.T. De Boer ◽

R.J. Pitman ◽

B. Macabeo ◽

A. Chit ◽

M.J. Postma ◽

...

Keyword(s):

United States ◽

Cost Effectiveness ◽

Influenza Vaccine ◽

The United States ◽

Trivalent Influenza Vaccine

Cost-Effectiveness Analysis of Quadrivalent Influenza Vaccine in Spain

Value in Health ◽

10.1016/j.jval.2015.09.1505 ◽

2015 ◽

Vol 18 (7) ◽

pp. A588

Author(s):

A Garcia Rojas ◽

RL Ortiz de Lejarazu ◽

J Reina ◽

D Callejo ◽

J Cuervo Uría ◽

...

Keyword(s):

Cost Effectiveness ◽

Influenza Vaccine ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Public Health And Economic Impact of A Quadrivalent Influenza Vaccine In Comparison to The Trivalent Influenza Vaccine In Brazil Over The Period Of 2010 – 2013

Value in Health ◽

10.1016/j.jval.2015.09.1927 ◽

2015 ◽

Vol 18 (7) ◽

pp. A578-A579 ◽

Cited By ~ 1

Author(s):

L Bricks ◽

JG Lopez ◽

B Macabeo ◽

AD Piedade ◽

OA Clark ◽

...

Keyword(s):

Public Health ◽

Influenza Vaccine ◽

Economic Impact ◽